RENOVION is a clinical stage pharmaceutical company that provides nebulized therapy.
Renovion company is a pharmaceutical corporation with therapy for chronic inflammatory airway diseases. The company’s flagship pharmaceutical product, Arina-1, is still in pre-clinical stages.Renovation was formed in 2013 to leverage a pharmaceutical discovery at the University of North Carolina-Chapel Hill that reduces infection and addresses airway inflammation through the use of a novel therapy – Arina-1.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 18, 2020 | Series A | $8.10M | 1 | White Rock Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
White Rock Capital | Yes | Series A |